Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harvard Pilgrim Health Care
Pharma
AZ extends outcomes-based dealmaking with two Symbicort pacts
AstraZeneca is looking to boost its key inhaler with two outcomes-based deals with regional insurers.
Eric Sagonowsky
Apr 19, 2018 9:58am
Cost watchdogs back Glaxo's $714K gene therapy
Jan 4, 2018 10:39am
AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon
May 30, 2017 11:44am
